Our Reports | Biosimilars & Generics | AAM
In the News - View AAM CEO Dan Leonard's blog on the essential role generic drugs play during COVID-19

Reports

AAM is continually adding new reports to our resource area with information on both generics and biosimilars. Below are some of our latest reports below – including data on how generic medicines can increase patient access to needed medicines, why generic medicines are essential to lowering health care costs, and how you can encourage your member of Congress to act in support on generic and biosimilar medicines.

For addition content about biosimilars, we encourage you to visit the Biosimilars Council website and their resources page

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.